These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8963170)

  • 21. New trends in the treatment of allergic conjunctivitis.
    Parys W; Blockhuys S; Janssens M
    Doc Ophthalmol; 1992; 82(4):353-60. PubMed ID: 1363981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind evaluation of topical levocabastine, a new specific H1 antagonist in patients with allergic conjunctivitis.
    Pipkorn U; Bende M; Hedner J; Hedner T
    Allergy; 1985 Oct; 40(7):491-6. PubMed ID: 2866725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Azelastine eye drops in the treatment of seasonal allergic conjunctivitis or rhinoconjunctivitis in young children.
    Sabbah A; Marzetto M
    Curr Med Res Opin; 1998; 14(3):161-70. PubMed ID: 9787982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of histamine-induced conjunctivitis to the assessment of a topical antihistamine, levocabastine.
    Feinberg G; Stokes TC
    Int Arch Allergy Appl Immunol; 1987; 82(3-4):537-8. PubMed ID: 2883131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levocabastine versus cromolyn sodium in the treatment of pollen-induced conjunctivitis.
    Ciprandi G; Cerqueti PM; Sacca S; Cilli P; Canonica GW
    Ann Allergy; 1990 Aug; 65(2):156-8. PubMed ID: 1974402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative efficacy of olopatadine 0.1% ophthalmic solution versus levocabastine 0.05% ophthalmic suspension using the conjunctival allergen challenge model.
    Abelson MB; Greiner JV
    Curr Med Res Opin; 2004 Dec; 20(12):1953-8. PubMed ID: 15701212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tolerability of levocabastine eye drops.
    Janssens M; Blockhuys S
    Doc Ophthalmol; 1993; 84(2):111-8. PubMed ID: 7905376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The early efficacy of topical levocabastine in patients with allergic conjunctivitis.
    Fujishima H; Fukagawa K; Takano Y; Okamoto S; Nakagawa Y; Uchio E; Yokoi N; Fukushima A; Takamura E
    Allergol Int; 2006 Sep; 55(3):301-3. PubMed ID: 17075271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and biological efficacy of preservative-free NAAGA eye-drops versus levocabastine eye-drops in vernal keratoconjunctivitis patients.
    Leonardi A; Bremond-Gignac D; Bortolotti M; Violato D; Pouliquen P; Delval L; Grouin JM; Fregona IA
    Br J Ophthalmol; 2007 Dec; 91(12):1662-6. PubMed ID: 17585003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the efficacy and tolerability of topical levocabastine and sodium cromoglycate in the treatment of seasonal allergic rhinoconjunctivitis in children.
    Vermeulen J; Mercer M
    Pediatr Allergy Immunol; 1994 Nov; 5(4):209-13. PubMed ID: 7894627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New therapeutic possibilities in vernal conjunctivitis].
    Popa DP; Papahagi V; Dinulescu A
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1984; 28(1):50-65. PubMed ID: 6145196
    [No Abstract]   [Full Text] [Related]  

  • 32. Topical levocabastine compared with oral loratadine for the treatment of seasonal allergic rhinoconjunctivitis. Swedish GP Allergy Team.
    Allergy; 1994 Sep; 49(8):611-5. PubMed ID: 7653738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of 0.05% levocabastine versus 4% sodium cromolyn in the allergen challenge model.
    Abelson MB; George MA; Smith LM
    Ophthalmology; 1995 Feb; 102(2):310-6. PubMed ID: 7862419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of topical levocabastine compared with oral terfenadine.
    Bahmer FA; Ruprecht KW
    Ann Allergy; 1994 May; 72(5):429-34. PubMed ID: 7909999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levocabastine eye drops do not affect accommodative capacity in volunteers and intraocular pressure in glaucoma patients.
    Wolf S; Wohlrab TM; Remky A
    Eur J Ophthalmol; 1995; 5(4):225-9. PubMed ID: 8963158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical levocabastine protects better than sodium cromoglycate and placebo in conjunctival provocation tests.
    Rimås M; Kjellman NI; Blychert LO; Björkstén B
    Allergy; 1990 Jan; 45(1):18-21. PubMed ID: 1968726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Multicenter evaluation of a new local antihistaminic drug (levocabastine)].
    Bischoff P; Gerber M
    Klin Monbl Augenheilkd; 1992 May; 200(5):354-7. PubMed ID: 1351957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of ketotifen eye drops in the treatment of seasonal allergic conjunctivitis.
    Kidd M; McKenzie SH; Steven I; Cooper C; Lanz R;
    Br J Ophthalmol; 2003 Oct; 87(10):1206-11. PubMed ID: 14507747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. To evaluate the efficacy and safety of olopatadine 0.1% ophthalmic solution and bepotastine 1.5% ophthalmic solution in patients with vernal keratoconjunctivitis in a tertiary care hospital.
    Sruthi V; Reddy RN; Sowmini K; Grace NS
    Indian J Pharmacol; 2020; 52(6):476-481. PubMed ID: 33666188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of antihistamine eye drops on the conjunctival provocation test with Japanese cedar pollen allergen.
    Dake Y; Enomoto T; Cheng L; Enomoto K; Shibano A; Ikeda H; Yoda S; Yajin S; Sakota T; Yamanishi E
    Allergol Int; 2006 Dec; 55(4):373-8. PubMed ID: 17130679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.